Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142355 |
| CAS No | NA |
| Mol.F. | C14H18N2O3 |
| Mol.Wt. | 262.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142356 |
| CAS No | NA |
| Mol.F. | C12H14N2O5 |
| Mol.Wt. | 266.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142357 |
| CAS No | NA |
| Mol.F. | C13H15N3O4 |
| Mol.Wt. | 277.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142358 |
| CAS No | NA |
| Mol.F. | C14H16FN3O4 |
| Mol.Wt. | 309.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142359 |
| CAS No | NA |
| Mol.F. | C16H18N2O3 |
| Mol.Wt. | 286.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142360 |
| CAS No | NA |
| Mol.F. | C16H14N2O3 |
| Mol.Wt. | 282.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142361 |
| CAS No | NA |
| Mol.F. | C16H10N2O4 |
| Mol.Wt. | 294.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142362 |
| CAS No | NA |
| Mol.F. | C17H16N2O3 |
| Mol.Wt. | 296.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142363 |
| CAS No | NA |
| Mol.F. | C33H30N4O5 |
| Mol.Wt. | 562.63 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142364 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142365 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142366 |
| CAS No | NA |
| Mol.F. | C20H15F7N2O4 |
| Mol.Wt. | 480.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142367 |
| CAS No | NA |
| Mol.F. | C23H20F7N5O4 |
| Mol.Wt. | 563.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142368 |
| CAS No | NA |
| Mol.F. | C24H24F7N5O5 |
| Mol.Wt. | 595.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142369 |
| CAS No | NA |
| Mol.F. | C4H7ClN4O3 |
| Mol.Wt. | 194.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142370 |
| CAS No | NA |
| Mol.F. | C11H12FN5O3 |
| Mol.Wt. | 281.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |